Cooper Investors PTY Ltd. bought a new stake in Corteva, Inc. (NYSE:CTVA – Free Report) in the second quarter, HoldingsChannel reports. The firm bought 31,719 shares of the company’s stock, valued at approximately $2,686,000. Corteva accounts for 1.2% of Cooper Investors PTY Ltd.’s investment portfolio, making the stock its 28th biggest position.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. JPL Wealth Management LLC purchased a new stake in shares of Corteva in the 3rd quarter worth about $25,000. Garton & Associates Financial Advisors LLC purchased a new position in Corteva during the 4th quarter valued at about $27,000. Bank of Jackson Hole Trust purchased a new position in Corteva during the 4th quarter valued at about $28,000. Cornerstone Financial Management LLC bought a new stake in Corteva during the fourth quarter worth about $29,000. Finally, Basepoint Wealth LLC bought a new stake in Corteva during the fourth quarter worth about $30,000. 81.54% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
CTVA has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $101.00 target price on shares of Corteva in a report on Monday. Morgan Stanley raised their price objective on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a research report on Thursday, May 28th. CICC Research lifted their price objective on Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Bank of America boosted their target price on Corteva from $90.00 to $96.00 and gave the stock a “buy” rating in a report on Monday, July 20th. Finally, UBS Group increased their target price on Corteva from $86.00 to $89.00 and gave the stock a “neutral” rating in a research note on Monday. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $91.38.
Corteva Stock Performance
Shares of CTVA opened at $78.18 on Wednesday. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $90.97. The business’s fifty day simple moving average is $82.05 and its two-hundred day simple moving average is $79.73. The company has a market cap of $52.16 billion, a price-to-earnings ratio of 51.77, a P/E/G ratio of 2.31 and a beta of 0.57. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07.
Corteva (NYSE:CTVA – Get Free Report) last posted its earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The business had revenue of $6.38 billion for the quarter, compared to analysts’ expectations of $6.60 billion. During the same quarter in the prior year, the business earned $2.20 EPS. The business’s revenue for the quarter was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Research analysts anticipate that Corteva, Inc. will post 3.74 earnings per share for the current fiscal year.
Corteva Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be issued a $0.18 dividend. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s dividend payout ratio (DPR) is currently 47.68%.
Corteva Company Profile
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Featured Articles
- Five stocks we like better than Corteva
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
